
A new bill proposed by Conservative peer Lord Saatchi has been given government backing as it seeks to become law …

Australian-based healthcare product development firm Admedus has appointed two new directors to its board. John Seaberg and Wayne Paterson (pictured) …
New research from the Royal Pharmaceutical Society shows that common ailments such as coughs and sore throats cost the NHS …

How did you find your way into your current role? When I was pursuing my doctorate in microbiology and immunology, …

GlaxoSmithKline says its potential Ebola vaccine will come ‘too late’ for the current outbreak despite being fast-tracked. In August the …

Pharmacyclics’s cancer drug Imbruvica will be tested in combination with Roche’s Gazyva in a new partnership announced by the firms. …
Medical supplier firm Woodley celebrated its 25-year anniversary this month at a lavish event at The Runway Visitor Park in …

The telehealth industry is on the verge of a dramatic growth surge that is significantly disrupting the healthcare sector in …

NICE has issued final draft guidance recommending Novartis’s Glivec for up to three years in people who have had a …
Red Door Communications (RDC) has promoted Matt Lowe and Katy Pogson to its board of directors, and Kate Aldous and …

Roche’s sales saw solid growth in the first nine months of the year, increased by the firm’s new cancer medicines. …

AstraZeneca along with its biologics R&D arm MedImmune are to enter into four new collaborations with the University of Cambridge. …

The FDA has approved both Roche’s Esbriet (pirfenidone) and Boehringer Ingelheim’s Ofev (nintedanib) for the treatment of the fatal lung …
NICE has issued preliminary draft guidance not recommending Dendreon’s therapeutic cancer vaccine Provenge for prostate cancer in people whose disease …

Novo Nordisk has appointed Jackie Scanlan to join its executive team as the corporate vice president of its human resources …

AbbVie will reconsider its planned $54.6 billion takeover of Shire in light of new US proposals designed to curb companies …

Cloud computing company Exostar has become a partner of BT for Life Sciences, allowing its Identity and Access Management (IAM) …

Medical device development firm VisionCare Ophthalmic Technologies has had its implantable miniature telescope for age-related macular degeneration disease approved by …

Eisai and Helsinn Healthcare’s Akynzeo (netupitant/palonosetron) has received FDA approval for the treatment of chemotherapy-induced nausea and vomiting (CINV). CINV …

The Scottish Lifesciences Association has named Dr Ken Sutherland as its new chair. Sutherland joins from Toshiba Medical Visualisation Systems …